Results

Total Results: 1,643 records

Showing results for "factors".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
    January 01, 2024 - than the proportion or total amount of fat, other macronutrients, or other modifiable lifestyle risk factors … Key Question 2 ● Minimum follow-up o If population has no CV risk factors (or unselected general … population): 10 years o If population has one or more CV risk factors: 5 years None Setting … Lifestyle factors as determinants of atherosclerotic cardiovascular health. … Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
    January 01, 2024 - than the proportion or total amount of fat, other macronutrients, or other modifiable lifestyle risk factorsFactors that could affect responses to single SFAs include (i) heterogeneity in susceptibility to desaturation … Key Question 2 ● Minimum follow-up o If population has no CV risk factors: 10 years o If population … has one or more CV risk factors (or unselected general population): 5 years None Setting ● General … Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
    August 01, 2016 - Review The value of omega 3 fatty acids (n-3 FA) intake to improve cardiovascular outcomes and risk factors … • What is the relative efficacy of different n-3 FA on CVD outcomes and risk factors? … • What are the effects of potential confounders or interacting factors—such as plasma lipids, body … • How does the efficacy or association of n-3 FA on CVD outcomes and risk factors differ by source … What is the relative efficacy of different n-3 FA on CVD outcomes and risk factors?
  4. effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
    March 29, 2012 - all observed pretreatment variables thought to have some connection to the outcome, all known risk factors … Risk Factors We now let C 0 be one or more baseline covariates measured at time zero. … Conditioning on such risk factors is unnecessary to remove bias but can result in efficiency gains … (e.g., trust in the medical system), economic factors (e.g., ability to pay), and institutional factors … The other variable selection criteria based on all pretreatment covariates and risk factors do not
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - For each AE associated with a particular vaccine, what are the risk factors for the AE (including age … For each AE associated with a particular vaccine, what are the risk factors for the AE (including age … Both patient factors (i.e., age and race) and vaccine factors (i.e., formulation, dosage, and timing … ) may be risk factors for potential AEs associated with vaccination. … (no unvaccinated group necessary, but must control for multiple factors in a regression analysis).
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
    April 01, 2007 - Data Elements The selection of data elements requires balancing such factors as their importance for … The motivating factors for participation at each level and the factors necessary to achieve retention … • Important exposures, risk factors, and mitigating (or protective) factors are identified and collected … , and mitigating or protective factors … • The role and impact of missing data and potential confounding factors have been explored.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
    March 13, 2012 - A number of negative prognostic factors (factors associated with increased risk of recurrence) have … The current system used to assess recurrence risk using the prognostic factors noted above (e.g., a … MSI testing is widely available and used along with clinical risk factors to help make decisions about … as analytic factors [such as reagents used].) … For articles that describe analytic validity: • Was information provided about preanalytic factors
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
    January 01, 2011 - claims totaled $25.5 billion, more than 30 percent of which was for supplementary classification of factors … puerperium E-codes* Digestive system diseases 2006 200920082007 * Supplementary classification of factors … accounting for the five highest Medicare reimbursements were: (1) Supplementary classification of factors … with those with the highest total reimbursements overall, except for Supplementary classification of factors … signs, and ill-defined conditions $ billion 20.5 22.3 24.3 25.5 * Supplementary classification of factors
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - prevention of surgical items left inside patient (surgical safety)  Medication administration  Human factors … Numerous factors have been postulated, and in some cases shown, to influence the effectiveness of a … patient safety practice, including contexts (such as safety culture, external factors and implementation … - Safety Culture, Teamwork, Leadership - Structural Organizational Characteristics - External Factors … Measure high-priority contexts in the 4 domains a) External factors, such as regulatory requirements
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_executive.pdf
    March 01, 2012 - A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile … Serum concentration of hyaluronan, IgM and IgA rheumatoid factors in a population based study of juvenile … Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared … Serum IgG and IgM rheumatoid factors by solid phase radioimmunoassay. … Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis.
  12. effectivehealthcare.ahrq.gov/products/sodium-potassium/research-protocol
  13. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/wic-outcomes-nutrition-protocol-amended.pdf
    October 01, 2020 - Does the association vary by participant factors such as: i. Age of the mother at delivery ii. … Does the association vary by participant factors such as: i. Age of the mother at delivery ii. … Synthesis of Qualitative Results: The qualitative evidence synthesis will provide contextual factors … We will consider important contextual factors, including population characteristics (e.g., WIC program … and WIC participant related factors) and intervention (and comparison group) characteristics that may
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
    January 31, 2013 - atherosclerotic disease of the coronary vessels, it is not surprising that PAD shares similar risk factors … The management of risk factors (i.e., tobacco use, diabetes, LDL levels, and hypertension) is considered … The decision to attempt revascularization in patients with CLI is based on a combination of factors, … Does the effectiveness of treatments vary by subgroup (age, sex, race, risk factors, comorbidities, … Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
    September 29, 2010 - OR “referral” OR diagnosis OR “predictive value of tests” OR “reproducibility of results” OR “sex factors … ” OR “age factors” OR anxiety OR comorbidity) AND (“ ANA test” OR “FANA test” OR “antinuclear antibod … Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology. … ti,ab. 72 or/184-186 13 or/119-128 73 exp demography/ 14 exp Lupus Erythematosus, Systemic/ 74 age factors … / or "age of onset"/ 15 (JSLE or SLE or "lupus erythematosus").ti,ab. 75 sex factors/ 16 exp Pain/di
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
    March 01, 2012 - What other medical, injury or treatment factors (i.e. orthopaedic resident cases, time?) … Venous thromboembolism: risk factors for recurrence. … Maynard (2010a) and Decousus (2010) – factors associated with bleeding risk. … Factors Associated with Prolonged Wound Drainage (Patel 2007) • THA – Factors associated with a prolonged … These factors were considered when assessing the applicability of the evidence. Freda C.
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
    May 02, 2025 - To assess whether pairwise meta-analysis will be appropriate, we will consider population factors such … as comorbidities, intervention factors such as intervention dose and frequency, and whether outcomes … In considering network meta-analysis, we will evaluate how these factors are distributed across direct … Based on EPC guidance, the SOE rating will be uninfluenced by these factors. … Factors important to consider include the type or extent of surgery participants in included studies
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
    September 01, 2021 - longer-term outcomes, and evaluate how benefits and harms according to demographic, clinical, and technical factors … and harms; analyses were conducted to assess how the control type, duration of symptoms, and other factors … evaluate how benefits and harms varied in subgroups defined by demographic, clinical, or technical factors … duration of pain, PMMA volume, requirement for bone edema on magnetic resonance imaging (MRI), and other factors … psychiatric or medical comorbidities), or technical (dose, intensity, duration, frequency, techniques) factors
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
    July 01, 2019 - Asymmetry in funnel plots can be difficult to detect visually, and may owe to multiple contributing factors … interpretation of the I2 statistic can be misleading, since the importance of inconsistency depends on several factors … Meta-regression • Meta-regression examines the degree to which study-level factors explain statistical … within a study. • Multiple meta-regression is also an option, and requires consideration of these factors
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
    January 01, 2009 - Therefore, it was decided that a technical brief to identify the contextual factors and the current

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: